Drug profile · INN
pantoprazole sodium
PANTOPRAZOLE SODIUM
pantoprazole sodium (PANTOPRAZOLE SODIUM) is a potassium-transporting atpase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — pantoprazole sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 2
- Programs
- 7
- Data quality
- 0.89
Quick answer
pantoprazole sodium (PANTOPRAZOLE SODIUM) is a potassium-transporting atpase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Primary target: Potassium-transporting ATPase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pantoprazole sodium?
pantoprazole sodium (PANTOPRAZOLE SODIUM) is a potassium-transporting atpase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pantoprazole sodium?
PANTOPRAZOLE SODIUM is a marketed brand name for pantoprazole sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pantoprazole sodium?
pantoprazole sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.